First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
36617365&utm_source= google_patent&utm_medium= platform_link&utm_campaign …

US PATENT DOCUMENTS OTHER PUBLICATIONS 4,676.980 A 6/1987 Segal et al.
4,816,567 A 3/1989 Cabilly et al. Amersham Biosciences," Antibody Purification, Handbook.” …

The present invention features methods for treating or preventing pain comprising
administering an amount of a nerve growth factor antagonist (such as an anti-NGF antibody) …

(62) Division of application No. 1 1/268,191, filed on Nov. 5,709,859 A 1/1998 Aruffo et al. 7,
2005, now Pat. No. 7,507,406, which is a division of 5,712, 120 A 1/1998 Rodriguez et al …

First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
32686099&utm_source= google_patent&utm_medium= platform_link&utm_campaign …

Related US Application Data 5,569,825 A 10/1996 Lonberg et al.(60) Provisional application
No. 60/676,093, filed on Apr. 5,580,717. A 12/1996 Dower et al. 29, 2005, provisional …

Monoclonal antibody 9TL and antibodies derived from 9TL directed against amyloid-beta
peptide and methods of using same for diagnosing and treatment of Alzheimer's disease …

The present invention provides novel antibodies specifically bind to an epitope on CD43
and CEA expressed on nonhe matopoietic cancer cells, but do not specifically bind to a …

The present application provides methods of purifying Aβ binding proteins having a Fc
region, for example, anti-Aβ antibodies or antibody fusions, by adsorbing the Aβ binding …

The invention provides a family of antibodies that specifically bind the human cell surface
glycosphingolipid GD2. The antibodies comprise modified variable regions, more specially …